Ammonia Solution, Strong

Ammonia Solution, Strong

SCHEMBL5316774

Cc1c2cccc1-2.N.O=C(O)N1CCCC2CC=CC=C21

nearest known ligand 0.31

Full drug profile on Sugi Atlas →

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
HSD11B1 P28845 2/20 0.31
ALDH1A1 P00352 1/20 0.31
LMNA P02545 1/20 0.31
HPGD P15428 1/20 0.31
HIF1A Q16665 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3306197 0.86
Hydrochloric Acid SCHEMBL11845673 0.85
SCHEMBL11142350 0.76 ALDH1A1 (0.46) HSD11B1ALDH1A1LMNAHPGDHIF1A
SCHEMBL11531912 0.70 ALDH1A1 (0.35) ALDH1A1LMNA
SCHEMBL10625679 0.66 L3MBTL1 (0.40) ALDH1A1
SCHEMBL11671846 0.66 ALDH1A1 (0.40) HSD11B1ALDH1A1LMNAHPGD
SCHEMBL11402517 0.66 MBTD1 (0.36) ALDH1A1LMNA
SCHEMBL23047083 0.65
SCHEMBL4674255 0.65
SCHEMBL9656113 0.65

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1812080-A2 GPR41 AND MODULATORS THEREOF FOR THE TREATMENT OF INSULIN-RELATED DISORDERS Arena Pharmaceuticals, Inc. (US) 2007-08-01 EP disclosed
WO-2006052566-A2 GPR41 AND MODULATORS THEREOF FOR THE TREATMENT OF INSULIN-RELATED DISORDERS ARENA PHARMACEUTICALS, INC. (US) 2006-05-18 WO disclosed